Modeling the VEGF-Bcl-2-CXCL8 pathway in intratumoral agiogenesis
From MaRDI portal
Publication:2426395
DOI10.1007/s11538-007-9242-9zbMath1281.92031OpenAlexW2000307813WikidataQ51907865 ScholiaQ51907865MaRDI QIDQ2426395
Jacques E. Nör, Trachette L. Jackson, Harsh Vardhan Jain
Publication date: 22 April 2008
Published in: Bulletin of Mathematical Biology (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1007/s11538-007-9242-9
Related Items (6)
Dynamics of a data based ovarian cancer growth and treatment model with time delay ⋮ Mathematical modeling of cellular cross-talk between endothelial and tumor cells highlights counterintuitive effects of VEGF-targeted therapies ⋮ A cell-based model of endothelial cell migration, proliferation and maturation during corneal angiogenesis ⋮ Vascular phenotype identification and anti-angiogenic treatment recommendation: a pseudo-multiscale mathematical model of angiogenesis ⋮ An integrated cellular and sub-cellular model of cancer chemotherapy and therapies that target cell survival ⋮ Multi-scale, multi-resolution brain cancer modeling
Uses Software
Cites Work
- Unnamed Item
- Competition and natural selection in a mathematical model of cancer
- Estimating the selective advantage of mutant p53 tumour cells to repeated rounds of hypoxia
- Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma
- Continuous and discrete mathematical models of tumor-induced angiogenesis
- Hopf point analysis for angiogenesis models
- Biological stoichiometry of tumor dynamics: Mathematical models and analysis
- A model of wound-healing angiogenesis in soft tissue
- A reinforced random walk model of tumour angiogenesis and anti-angiogenic strategies
- A mathematical model for the roles of pericytes and macrophages in the initiation of angiogenesis. I: The role of protease inhibitors in preventing angiogenesis
- Implementing Radau IIA methods for stiff delay differential equations
This page was built for publication: Modeling the VEGF-Bcl-2-CXCL8 pathway in intratumoral agiogenesis
